KXII Health Headlines

Unapproved device buys time for new pair of lungs

Posted: 07/02/2014 - PITTSBURGH (AP) - An Oklahoma man is slowly gaining strength at a Pittsburgh hospital with a second set of transplanted lungs in a procedure that was possible only through a device that until now hasn't been used in the U.S.

Warning signs and how to prevent a drowning

Updated: 06/19/2014 - DENISON, TX -- As the temperatures rise in Texoma, lifeguards and emergency crews are concerned about an increase in drowning accidents as more people hit the water.

FDA prepping long-awaited plan to reduce salt

Posted: 06/17/2014 - WASHINGTON (AP) - Food companies and restaurants could soon face government pressure to make their foods less salty - a long-awaited federal effort to try to prevent thousands of deaths each year from heart disease and stroke.

Safe Family: BB gun problems

Posted: 05/22/2014 - IOWA -- An Iowa woman is warning parents about the dangers of BB guns. She was hit in the chest and it is now lodged in her body. Vanessa Peng has her story in today's safe family report.

Kids get codeine in ER despite risks, guidelines

Posted: 04/21/2014 - CHICAGO (AP) - Despite recommended limits on codeine use in children, the potent painkiller is prescribed for children in at least half a million emergency room visits each year, a study suggests.

More KXII Health Headlines

CBS News Health Headlines

WebMD Health News

AP Top Health Stories

  • European regulators recommend approval of Orexigen's obesity pill
    (Reuters) - Orexigen Therapeutics Inc said European regulators recommended the approval of the drugmaker's obesity pill on Friday. The European Commission is expected to give its decision on the drug in early 2015, the company said. The drug, Mysimba, is already sold as Contrave in the United States by Orexigen's partner Takeda Pharmaceutical Co. (Reporting by Natalie Grover in Bengaluru; Editing by Siddharth Cavale)
  • Orexigen diet pill recommended for approval in Europe
    LONDON (Reuters) - A new diet pill from Orexigen Therapeutics Inc has been recommended for approval in Europe, the European Medicines Agency (EMA) said on Friday. The drug, known as Contrave in the United States, will be marketed as Mysimba in Europe. The medicine won U.S. approval in September and is a combination of the antidepressant bupropion and Orexigen's formulation of naltrexone, designed to prevent drug dependence. ...
  • Futures edge higher after two-day rally

    Man carries an umbrella in the rain as he passes the New York Stock ExchangeNEW YORK (Reuters) - U.S. stock index futures edged higher on Friday, putting the S&P 500 on track to extend gains after the benchmark index scored its best two-day run in three years.

  • Alstom shareholders back 12.35 billion euro sale of power arm to GE

    The logo of Alstom is pictured during an inaugural visit of the Alstom offshore wind turbine plants in Montoir-de-BretagnePARIS (Reuters) - Alstom shareholders on Friday backed with 99.2 percent of votes the French engineering group's plan to sell most of its power equipment business to General Electric and refocus on its smaller rail arm.

  • U.S. environment agency set to issue long-anticipated rules for coal ash disposal
    By Jonathan Kaminsky (Reuters) - The U.S. Environmental Protection Agency is due to issue long-anticipated regulations on Friday for the disposal of coal ash, a byproduct of coal-based power production that contains toxic materials such as arsenic and lead. The agency, which agreed to the Friday deadline to settle a lawsuit filed by environmental groups, first proposed rules governing coal ash storage in 2010. That was in the wake of a massive spill at a ruptured holding pond in Tennessee that has cost more than $1 billion to clean up. ...
Sherman 4201 Texoma Pkwy (903) 892 -8123 Ardmore 2624 S. Commerce (580) 223-0946
Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability
Gray Television, Inc.